BC Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
Location status: Recruiting
Location contact
Anthony Cooper, FRCSC
PRINCIPAL_INVESTIGATOR
Emily Schaeffer, PhD
CONTACT
Kishore Mulpuri, FRCSC
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05361980
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.
Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.
Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).
Interested in participating?
Request Info0 year–25 year
All sexes
Observational
Vancouver, British Columbia, V6H 3N1, Canada
Location status: Recruiting
Anthony Cooper, FRCSC
PRINCIPAL_INVESTIGATOR
Emily Schaeffer, PhD
CONTACT
Kishore Mulpuri, FRCSC
PRINCIPAL_INVESTIGATOR
STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.
Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.
Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.
Required Data Collection:
Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.
The following data will be collected and entered into the registry:
Follow-up Procedures
Data collected during routine standard of care follow-up visits will be collected as part of this study. The following data will be collected:
The condition-specific registries are designed to capture every visit that occurs, whether scheduled or unscheduled. An unscheduled visit may occur when an adverse event occurs, or when a patient returns outside of the planned interval window. If an unscheduled visit occurs, the following assessments are to be done:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient receives a pediatric orthopaedic implant as a part of standard clinical care.
Time frame: 2 years post implant insertion
Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed.
Time frame: 2 years post implant insertion
Determine the implant survival rate at post-operative end-point: (lack of revision)
Time frame: 2 years post implant insertion
Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction.
Time frame: 2 years post implant insertion
The numeric pain rating scale (NPRS) is a subjective, 11-point numerical scale in which respondents self-report their pain on a scale of 0 (no pain at all) to 10 (worst pain imaginable).
Time frame: 2 years post implant insertion
LIMB-Q Kids is a new patient reported outcome measure (PROM) for children with lower limb deformities.
Time frame: 2 years post implant insertion
The Patient Reported Outcomes Measurement Information System (PROMIS) measures are self-reported and parent-reported. It includes over 300 measures of global, physical, mental, and social health for adults and children in the general population and those living with a chronic condition. Specifically, the PROMIS Global Health will be administered to all patients while the PROMIS Physical Function - Mobility short form will be administered to those with an implant used in a lower extremity and the PROMIS Physical Function - Upper Extremity short form will be administered to those with an implant used in an upper extremity.
Contact information is provided by the study sponsor or research team.
University of British Columbia
Other
Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program
Acronym: Global POISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01820611
Arthritis, Arthritis, Rheumatoid
Turku, Finland
View Trial DetailsNCT01343693
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Montgomery, Alabama, United States
View Trial DetailsNCT07430345
Agnosia, Fracture
Camden, New Jersey, United States
View Trial DetailsNCT05699174
Amputation, Antibiotic Side Effect
Indianapolis, Indiana, United States
View Trial Details